Firstly, compared with eCO, FeNO may exhibit less involvement in metabolic pathways30, since eCO can stimulate insulin and glucagon release from islet cells as well as modulate insulin sensitivity and glucose tolerance in metabolic disorder animals29. The gene discussed is GCG; the disease is metabolic disease.